[EN] 3-[4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL]OCTANE- OR HEPTANE-NITRILE AS JAK INHIBITORS<br/>[FR] 3-[4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL]OCTANE- OU HEPTANE-NITRILE EN TANT QU'INHIBITEURS DE JAK
申请人:INCYTE CORP
公开号:WO2010135621A1
公开(公告)日:2010-11-25
The present invention relates to the Janus kinase (JAK) inhibitors 3-[4-(7H-pyrrolo[2,3- d]pyrimidin-4-yl)-1H-pyrazol-l-yl]octanenitrile or 3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-y1)-1H- pyrazol-l-yl]heptanenitrile, as well as its compositions and methods of use, which is useful in the treatment of JAK-associated diseases including, for example, inflammatory and autoimmune disorders, skin disorders, cancer, and other diseases.
本发明涉及Janus激酶(JAK)抑制剂3-[4-(7H-吡咯[2,3-d]嘧啶-4-基)-1H-吡唑-1-基]辛腈或3-[4-(7H-吡咯[2,3-d]嘧啶-4-基)-1H-吡唑-1-基]庚腈,以及其组合物和使用方法,该方法在治疗与JAK相关的疾病方面具有用处,包括炎症性和自身免疫性疾病、皮肤疾病、癌症和其他疾病。